Ascent Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ASCENT PHARMS INC, and what generic and branded alternatives to ASCENT PHARMS INC drugs are available?
ASCENT PHARMS INC has forty approved drugs.
Drugs and US Patents for Ascent Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ascent Pharms Inc | GEMFIBROZIL | gemfibrozil | TABLET;ORAL | 214603-001 | Jan 13, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ascent Pharms Inc | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 207419-003 | Mar 22, 2017 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ascent Pharms Inc | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 207418-001 | Aug 7, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ascent Pharms Inc | LEVOTHYROXINE SODIUM | levothyroxine sodium | TABLET;ORAL | 215259-006 | Jan 18, 2023 | AB4 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ascent Pharms Inc | IBUPROFEN AND FAMOTIDINE | famotidine; ibuprofen | TABLET;ORAL | 216814-001 | Mar 15, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ascent Pharms Inc | BENZONATATE | benzonatate | CAPSULE;ORAL | 211518-002 | Feb 22, 2019 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ASCENT PHARMS INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
Similar Applicant Names
Here is a list of applicants with similar names.